| 1 |
High burden of infections in Indian patients with Idiopathic Inflammatory Myopathy: validation of observations from the MyoCite dataset |
|
| | Rudrarpan Chatterjee,Pankti Mehta,Vikas Agarwal,Latika Gupta | | | Rheumatology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic |
|
| | R. Naveen,T. G. Sundaram,Vikas Agarwal,Latika Gupta | | | Rheumatology International. 2021; 41(1): 67 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort |
|
| | R. Naveen,Upendra Rathore,Vikas Agarwal,Latika Gupta | | | Rheumatology International. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India |
|
| | Pankti Mehta,Vikas Agarwal,Latika Gupta | | | Rheumatology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Serum fatty acid-binding protein 3 levels differentiate active from inactive myositis and correlate with response to therapy |
|
| | Latika Gupta,Sanjukta Majumder,Amita Aggarwal,Ramnath Misra,Able Lawrence | | | Indian Journal of Rheumatology. 2020; 15(6): 187 | | | [Pubmed] [Google Scholar] [DOI] | |
|
